Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03297762 · ClinicalTrials.gov registry record · NA
Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT03297762: Clinical Trial NA study, sponsored by Stanford University.
NCT03297762 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03297762, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).
Primary Outcome
amount of time per week CGM is used
Interventions
- BEHAVIORAL gamification
- BEHAVIORAL Use of Dexcom G5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
Why NCT03297762 stopped before completion
NCT03297762 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which gamification is the first listed.
NCT03297762 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03297762 about?
NCT03297762 is a clinical study titled "Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes". To use an enhanced continuous glucose monitor (CGM) experience, including an automated CGM-electronic health record (EHR) data integration system, proactive interventions, and gamification techniques, to increase CGM use among publicly-insured youth with type 1 diabetes (T1D).
What is the current status of trial NCT03297762?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2018-05-07. Estimated completion is 2019-06-01.
What interventions are being tested in trial NCT03297762?
The interventions under investigation include: gamification (BEHAVIORAL), Use of Dexcom G5 (BEHAVIORAL).
Who is sponsoring clinical trial NCT03297762?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03297762's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI